Video

Safety Profile of S1P Receptor Modulators for Multiple Sclerosis

Author(s):

Krzysztof Selmaj, MD, PhD

Krzysztof Selmaj, MD, PhD, discusses the side effects of sphinogine-1-phospate (S1P) receptor modulators, highlighting particular adverse events clinicians should be aware of when treating multiple sclerosis (MS).

Related Videos
Bruce Bebo, PhD
Lauren B. Krupp, MD
Amit Bar-Or, MD, FRCPC, FAAN, FANA
Sarah Levy, PhD
Enrique Alvarez, MD, PhD
Related Content
IJMSC Insights
April 23rd 2025

IJMSC Insights: Kathleen Costello, Interim CEO of CMSC

Kathleen Costello, CRNP, MSCN Erin E Gyomber
Neurology Unwrapped: 2024’s Most Intriguing Conversations
December 27th 2024

Neurology Unwrapped: 2024’s Most Intriguing Conversations

Marco Meglio
This Week on NeurologyLive® — April 21, 2025
April 21st 2025

This Week on NeurologyLive® — April 21, 2025

NeurologyLive® Staff
Episode 125: Understanding Major Changes to New McDonald Criteria for Multiple Sclerosis
October 4th 2024

Episode 125: Understanding Major Changes to New McDonald Criteria for Multiple Sclerosis

Marco Meglio
This Week on NeurologyLive® — April 14, 2025
April 14th 2025

This Week on NeurologyLive® — April 14, 2025

NeurologyLive® Staff
NeurologyLive® Friday 5 — April 11, 2025
April 11th 2025

NeurologyLive® Friday 5 — April 11, 2025

NeurologyLive® Staff
© 2025 MJH Life Sciences

All rights reserved.